U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    Form 10-Q

Mark One
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
    ACT OF 1934

    For the quarterly period ended March 31, 2011

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
    ACT OF 1934

    For the transition period from ____________ to _____________

                         Commission File No. 333-149857

                               Global NuTech, Inc.
                 (Name of small business issuer in its charter)

           Nevada                                                26-0338889
(State or other jurisdiction of                               (I.R.S. Employer
 incorporation or organization)                              Identification No.)

     5412 Bolsa Avenue, Suite D
         Huntington Beach, CA                                      92649
(Address of principal executive offices)                         (Zip Code)

                                 (714) 373-1930
                            Issuer's telephone number

      Securities registered under Section 12(b) of the Exchange Act: NONE.

         Securities registered under Section 12(g) of the Exchange Act:

             Shares of Common Stock, $0.00001 Par Value Per Share.

Indicate by check mark whether the issuer (1) filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
past 12 months (or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing requirements for the
past 90 days. Yes [X] No [ ]

Indicate by check mark whether by check mark whether the registrant has
submitted electronically and posted on its corporate Website, if any, every
Interactive Data File required to be submitted pursuant to Rule 405 of
Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months
or for such shorter period that the registrant was required to submit such
files). Yes [ ] No [X]

Indicate by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting company. See
the definitions of "large accelerated filer", an "accelerated filer" and
"smaller reporting company" in Rule 12b-2 of the Exchange Act."

Large accelerated filer [ ]                        Accelerated filed [ ]
Non-accelerated filer [ ]                          Smaller reporting company [X]
(Do not check if smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act). Yes [ ] No [X]

                   (APPLICABLE ONLY TO CORPORATE REGISTRANTS)

Indicate the number of shares outstanding of each of the registrant's classes of
common stock, as of the latest  practicable date. As of May 11, 2011, the Issuer
had 514,287,619 Shares of Common Stock outstanding.

                       DOCUMENTS INCORPORATED BY REFERENCE

List hereunder the following documents if incorporated by reference and the Part
of the Form 10-Q  (e.g.  Part I, Part II,  etc.)  into  which  the  document  is
incorporated:  (1) Any  annual  report  to  security  holders;  (2) Any proxy or
information  statement;  and (3) Any prospectus  filed pursuant to Rule 424b) or
(c) under the  Securities Act of 1933.  The listed  documents  should be clearly
described for identification  purposes (e.g.,  annual report to security holders
for fiscal year ended December 24, 1980). Not applicable.
<PAGE>
                               Global NuTech, Inc.
                       (Formerly known as Bio-Clean, Inc.
                          (A Development Stage Company)

                                Table of Contents

PART I - FINANCIAL INFORMATION

Item 1.  Financial Statements                                                  3

         Balance Sheets as of March 31, 2011 (Unaudited) and
         December 31, 2010 (Audited)                                           3

         Statements of Operations for the three-month ended
         March 31, 2011 and 2010, and from May 22, 2007 (Inception)
         through March 31, 2011 (Unaudited)                                    4

         Statements of Cash Flows as of March 31, 2011 and 2010, and from
         May 22, 2007 (Inception) through March 31, 2011 (Unaudited)           5

         Notes to the Financial Statements (Unaudited)                         6

Item 2.  Management's Discussion and Analysis of Financial Condition and
         Results of Operations                                                13

Item 3.  Quantitative and Qualitative Disclosures About Market Risk           15

Item 4.  Controls and Procedures                                              15

PART II - OTHER INFORMATION

Item 1.  Legal Proceedings                                                    15

Item 1A. Risk Factors                                                         15

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds          16

Item 3.  Defaults Upon Senior Securities                                      16

Item 4.  (Removed and Reserved)                                               16

Item 5.  Other Information                                                    16

Item 6.  Exhibits                                                             16

                                       2
<PAGE>
                         PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS.

                       Global NuTech, Inc. and Subsidiary
                       (Formerly Known as Bio-Clean, Inc.)
                          (A Development Stage Company)
                           CONSOLIDATED BALANCE SHEETS

<TABLE>
<CAPTION>
                                                                                    March 31,            December 31,
                                                                                      2011                   2010
                                                                                  ------------           ------------
                                                                                  (Unaudited)
<S>                                                                               <C>                    <C>
                                     ASSETS

Current Assets
  Cash and cash equivalents                                                       $        941           $        989
                                                                                  ------------           ------------
Total Current Assets                                                                       941                    989
                                                                                  ------------           ------------

Total Assets                                                                      $        941           $        989
                                                                                  ============           ============

                      LIABILITIES AND STOCKHOLDERS' DEFICIT

Current Liabilities
  Accrued expenses                                                                $     27,943           $      1,266
  Advance from related parties                                                         149,886                122,559
  Note payable to related party - current portion                                        8,913                 29,956
                                                                                  ------------           ------------
Total Current Liabilities                                                              186,742                153,781
                                                                                  ------------           ------------
Notes payable                                                                           20,000                 20,000
                                                                                  ------------           ------------

Total Liabilities                                                                      206,742                173,781
                                                                                  ------------           ------------
Stockholders' Deficit
  Capital stock:
    Preferred Stock, $0.00001 par value, 100,000,000 shares authorized:
    Preferred Stock, Series A, $0.00001 par value, 5,000,000 shares
     authorized; 0 shares issued and outstanding at March 31, 2011 and
     December 31, 2010, respectively                                                        --                     --
    Preferred Stock, Series B, $0.00001 par value, 250,000 shares authorized;
     0 shares issued and outstanding at March 31, 2011 and
     December 31, 2010, respectively                                                        --                     --
    Preferred Stock, Series C, $0.00001 par value, 80,000 shares authorized;
     20,000 shares issued and outstanding at March 31, 2011 and
     December 31, 2010,  respectively                                                       --                     --
    Common Stock, $0.00001 par value, 1,400,000,000 shares authorized;
     514,287,619 and 188,810,000 shares issued and outstanding at
     March 31, 2011 and December 31, 2010, respectively                                  2,889                  1,889
    Additional Paid in Capital                                                       1,490,004              1,271,111
    Deficit accumulated during the development stage                                (1,698,694)            (1,445,792)
                                                                                  ------------           ------------
Total Stockholders' Deficit                                                           (205,801)              (172,792)
                                                                                  ------------           ------------

Total Liabilities and Stockholders' Deficit                                       $        941           $        989
                                                                                  ============           ============
</TABLE>


   The accompanying notes are an integral part of these financial statements.

                                       3
<PAGE>
                       Global NuTech, Inc. and Subsidiary
                       (Formerly Known as Bio-Clean, Inc.)
                          (A Development Stage Company)
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                                  (Unaudited)

<TABLE>
<CAPTION>
                                                                                              Cumulative From
                                                                                               May 22, 2007
                                                 For The Three Months Ended March 31,         (Inception) to
                                                 -----------------------------------             March 31,
                                                     2011                   2010                   2011
                                                 ------------           ------------           ------------
<S>                                              <C>                    <C>                    <C>
Revenues                                         $         --           $         --           $         --
                                                 ------------           ------------           ------------
Operating Expenses
  General and administrative                           99,975                 21,258                955,500
  Compensation to officer for services                151,250                     --                163,250
                                                 ------------           ------------           ------------
      Total Operating Expenses                        251,225                 21,258              1,118,750

Other (Income) Expenses
  Interest expense                                        877                     --                  1,344
  Impairment of investment in joint ventures               --                     --                577,000
                                                 ------------           ------------           ------------
                                                          877                     --                578,344

Loss from operations before income taxes             (252,102)               (21,258)            (1,697,094)

Provision for income taxes                                800                     --                  1,600
                                                 ------------           ------------           ------------

Net Loss                                         $   (252,902)          $    (21,258)          $ (1,698,694)
                                                 ============           ============           ============

Net loss per share - basic and diluted           $      (0.00)          $      (0.00)
                                                 ============           ============
Weighted average number of common
 shares outstanding                               319,360,150             81,810,000
                                                 ============           ============
</TABLE>


   The accompanying notes are an integral part of these financial statements.

                                       4
<PAGE>
                       Global NuTech, Inc. and Subsidiary
                       (Formerly Known as Bio-Clean, Inc.)
                          (A Development Stage Company)
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                  (Unaudited)

<TABLE>
<CAPTION>
                                                                                                      Cumulative From
                                                                                                        May 22, 2007
                                                           For The Three Months Ended March 31,        (Inception) to
                                                           -----------------------------------            March 31,
                                                               2011                   2010                  2011
                                                           ------------           ------------          ------------
<S>                                                         <C>                    <C>                    <C>

CASH FLOWS FROM OPERATING ACTIVITIES
  Reconciliation of net loss to net cash
   used in operating activities:
     Net loss                                              $   (252,902)          $    (21,258)         $ (1,698,694)
     Issuance of stock to officers for services                  86,250                     --                98,250
     Impairment of stock issued for joint ventures                   --                     --               577,000
     Issuance of stock to consultants for services              112,800                     --               742,800
  (Increase) decrease in current assets and liabilities:
     Increase (decrease) in accrued expenses                     26,477                 21,258                27,744
     Increase in advances from related party                     27,327                     --               179,841
                                                           ------------           ------------          ------------
Net cash used in operating activities                               (48)                    --               (73,059)
                                                           ------------           ------------          ------------

CASH FLOWS FROM INVESTING ACTIVITIES                                 --                     --                    --
                                                           ------------           ------------          ------------
CASH FLOWS FROM FINANCING ACTIVITIES
  Cash proceeds from notes payable                                   --                     --                20,000
  Cash proceeds from sale of common stock                            --                     --                54,000
                                                           ------------           ------------          ------------
Net cash provided by financing activities                            --                     --                74,000
                                                           ------------           ------------          ------------

Net increase (decrease) in cash and cash equivalents                (48)                    --                   941

Cash and cash equivalents - beginning of the period                 989                     --                    --
                                                           ------------           ------------          ------------

Cash and cash equivalents - end of the period              $        941           $         --          $        941
                                                           ============           ============          ============
SUPPLEMENTAL CASH FLOW INFORMATION:

Cash paid for:
  Interest                                                 $         --           $         --          $         --
                                                           ============           ============          ============
  Income taxes                                             $         --           $         --          $         --
                                                           ============           ============          ============

SUPPLEMENTAL DISCLOSURE ON NON-CASH INVESTING AND
FINANCING ACTIVITIES:
  Conversion of debt to Note Payable                       $         --           $         --          $     29,756
                                                           ============           ============          ============
  Conversion of note payable to common stock               $     20,843           $         --          $     20,843
                                                           ============           ============          ============
</TABLE>


   The accompanying notes are an integral part of these financial statements.

                                       5
<PAGE>
                       GLOBAL NUTECH, INC. AND SUBSIDIARY
                          (A Development Stage Company)
                   Notes to Consolidated Financial Statements
                                 March 31, 2011
                                   (Unaudited)


1. ORGANIZATION AND BUSINESS OPERATIONS

Global NuTech, Inc., formerly Bio-Clean,  Inc., ("the Company") was incorporated
under the laws of the State of Nevada,  U.S. on May 22, 2007. In September 2010,
the Company  changed its name to Global  NuTech,  Inc. In  September  2009,  the
Company  effectuated a nine for one forward stock split of its common stock. The
Company  is  in  the  development  stage  as  defined  under  Development  Stage
Enterprises  (ASC 15). From it's inception,  the Company has been engaged in the
marketing  and  distribution  of various  products.  Initially,  the Company was
involved  with the  marketing  and  distribution  of  beauty  products  in North
America.  In the fall of 2010,  the Company  shifted it's focus to the marketing
and sales of dietary  supplements  for both humans and animals.  The Company has
not generated any revenue to date and consequently its operations are subject to
all risks inherent in the  establishment of a new business  enterprise.  For the
period from  inception,  May 22, 2007 through  March 31,  2011,  the Company has
accumulated losses of $1,698,694.

On September 15, 2010, the Company  acquired 100% ownership  interest in E-Clean
Acquisitions  Corporation  ("EAC"),  a Nevada  corporation  for an investment of
$100.  The purpose of  acquisition  of EAC was for this  wholly-owned  entity to
acquire other entities or enter into joint venture business partnerships.

GOING CONCERN
The Company's  consolidated  financial statements are prepared using the accrual
method of  accounting  and have  been  prepared  in  accordance  with  generally
accepted  accounting  principles in the United States of America.  The financial
statements have been prepared on a going concern basis which assumes the Company
will be able to realize its assets and discharge its  liabilities  in the normal
course of business for the foreseeable  future.  The Company has incurred losses
since  inception  resulting in an accumulated  deficit of $1,698,694 as of March
31, 2011 and further losses are  anticipated in the  development of its business
raising  substantial  doubt about the  Company's  ability to continue as a going
concern.  The  ability to  continue  as a going  concern is  dependent  upon the
Company  generating  profitable  operations  in the future  and/or to obtain the
necessary  financing to meet its obligations  and repay its liabilities  arising
from  normal  business  operations  when they come due.  Management  intends  to
finance  operating  costs over the next twelve  months  with loans from  related
parties and or private placement of common stock.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

PRINCIPLES OF CONSOLIDATION
The  consolidated  financial  statements  include the accounts of Global NuTech,
Inc. and its  wholly-owned  subsidiary  E-Clean  Acquisitions  Corporation.  All
material intercompany transactions have been eliminated in the consolidation.

Use of Estimates and Assumptions
The preparation of financial  statements in conformity  with generally  accepted
accounting  principles  in the United States of America  requires  management to
make estimates and  assumptions  that affect the reported  amounts of assets and
liabilities  and disclosure of contingent  assets and liabilities at the date of
the  financial  statements  and the  reported  amounts of revenues  and expenses
during the reporting period. Actual results could differ from those estimates.

CASH AND CASH EQUIVALENTS
The Company  considers  all highly liquid  instruments  with a maturity of three
months or less at the time of issuance to be cash equivalents.

FOREIGN CURRENCY TRANSLATION
The  Company's  functional  currency  and its  reporting  currency is the United
States dollar.

                                       6
<PAGE>
FAIR VALUE OF FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS
ASC 820, Fair Value Measurements and Disclosures, requires an entity to maximize
the use of observable  inputs and minimize the use of  unobservable  inputs when
measuring fair value.  ASC 820  establishes a fair value  hierarchy based on the
level of independent,  objective evidence surrounding the inputs used to measure
fair  value.  A  financial  instrument's  categorization  within  the fair value
hierarchy  is based upon the lowest  level of input that is  significant  to the
fair value  measurement.  ASC 820  prioritizes the inputs into three levels that
may be used to measure fair value:

LEVEL 1
Level 1 applies to assets or  liabilities  for which there are quoted  prices in
active markets for identical assets or liabilities.

LEVEL 2
Level 2 applies to assets or  liabilities  for which there are inputs other than
quoted  prices that are  observable  for the asset or  liability  such as quoted
prices for similar assets or liabilities  in active  markets;  quoted prices for
identical  assets  or  liabilities  in  markets  with  insufficient   volume  or
infrequent  transactions (less active markets);  or model-derived  valuations in
which significant  inputs are observable or can be derived  principally from, or
corroborated by, observable market data.

LEVEL 3
Level 3 applies to assets or liabilities for which there are unobservable inputs
to the valuation methodology that are significant to the measurement of the fair
value of the assets or liabilities.

The  Company's  financial  instruments  consist  principally  of  cash,  amounts
receivable, accounts payable and amounts due to related parties. Pursuant to ASC
820, Fair Value Measurements and Disclosures and ASC 825, Financial Instruments,
the fair value of our cash  equivalents is determined based on "Level 1" inputs,
which  consist of quoted  prices in active  markets for  identical  assets.  The
Company  believes  that  the  recorded  values  of all of  the  other  financial
instruments  approximate  their current fair values  because of their nature and
respective maturity dates or durations.

STOCK-BASED COMPENSATION
In  accordance  with ASC 718,  Compensation  - Stock  Compensation,  the Company
accounts for share-based  payments using the fair value method. All transactions
in which goods or services  are the  consideration  received for the issuance of
equity   instruments   are  accounted  for  based  on  the  fair  value  of  the
consideration  received  or the fair  value  of the  equity  instrument  issued,
whichever is more reliably  measurable.  To date,  the Company has not adopted a
stock option plan and has not granted any stock options.

INCOME TAXES
Income  taxes are  accounted  for in  accordance  with  Statement  of  Financial
Accounting Standards No. 109 (ASC 740),  Accounting for Income Taxes. A deferred
tax  asset or  liability  is  recorded  for all  temporary  differences  between
financial and tax reporting and net operating loss carry-forwards.  Deferred tax
expense  (benefit)  results from the net change  during the year of deferred tax
assets and liabilities. Deferred tax assets are reduced by a valuation allowance
when, in the opinion of management, it is more likely than not that some portion
of all of the  deferred  tax assets will be  realized.  Deferred  tax assets and
liabilities are adjusted for the effects of changes in tax laws and rates on the
date of enactment.

BASIC AND DILUTED NET LOSS PER SHARE
In February 1997, the FASB issued ASC 260, "Earnings Per Share", which specifies
the computation,  presentation  and disclosure  requirements for earnings (loss)
per share for entities with publicly held common stock.  ASC 260  supersedes the
provisions of APB No. 15, and requires the presentation of basic earnings (loss)
per share and  diluted  earnings  (loss) per share.  The Company has adopted the
provisions of ASC 260 effective May 22, 2007 (inception date).

                                       7
<PAGE>
Basic net loss per share  amount is  computed  by  dividing  the net loss by the
weighted average number of common shares outstanding. Diluted earnings per share
are the same as basic  earnings  per share  because  diluted  earnings per share
gives effect to all potentially  dilutive common shares  outstanding  during the
period.  Diluted EPS excludes all potentially dilutive shares since their effect
is anti-dilutive.

COMPREHENSIVE LOSS
ASC 220,  Comprehensive  Income,  establishes  standards  for the  reporting and
display of  comprehensive  income (loss) and its components in the  consolidated
financial  statements.  As at March 31, 2011 and 2010,  the Company has no items
that represent a comprehensive income (loss) and, therefore,  has not included a
schedule  of  comprehensive   income  (loss)  in  the   consolidated   financial
statements.

RECENT ACCOUNTING PRONOUNCEMENTS
We have reviewed all the recent  accounting  pronouncements  through ASU 2010-19
and do not believe any of these  pronouncements  will have a material  impact on
the Company.

3. INVESTMENT IN SUBSIDIARY

On September 15, 2010, the Company  acquired 100%  ownership  interest in EClean
Acquisition Corporation (EAC) from an officer of the Company for a consideration
of $100. EAC had no assets,  no  liabilities  and  accumulated  loss of $100. On
February 22, 2011, the Company issued  225,500,000 shares of its common stock to
EAC for acquisition of business entities.  EAC did not make any acquisitions and
held the shares issued as of March 31, 2011.

4. INVESTMENT IN JOINT VENTURES AND IMPAIRMENT

On September 29, 2010, the Company's wholly-owned subsidiary EAC entered into an
agreement to invest in a Joint Venture ("JV") with Robert Kavanaugh d/b/a Biotec
Foods,  a/k/a Agrigenic Food Company  ("Agrigenic").  Both the parties  mutually
agreed to amend the closing  date of the JV to October 8, 2010.  Under the terms
of the JV, EAC will provide  marketing,  distribution  and sales for  Agrigenic,
including its lines of dietary  supplements  for humans and animals for a period
of ten years.  Pursuant to the terms of the JV, net profits  will be divided 60%
to Agrigenic and 40% to EAC. On October 8, 2010, the Company  issued  50,000,000
restricted  shares of its common stock  valued at $325,000  pursuant to Rule 144
restrictions  of the Securities and Exchange Act of 1933, for EAC's 40% share of
investment in the JV. At December 31, 2010,  the Company  recorded an impairment
of $325,000 in its  financial  statements  for its  investment  in the JV. As of
March 31, 2011, the business activities in the JV have not started and it is not
known to both  the  parties  when the JV is  expected  to start  their  business
operations.

On October 31, 2010,  the Company's  wholly owned  subsidiary EAC entered into a
Joint  Venture  Agreement  with HIGA  Corporation  ("HIGA") for a ten year term.
Under  the  Joint  Venture  Agreement,   the  Company  will  provide  marketing,
distribution and sales for HIGA, including various rubber products, both generic
in design and custom designed for specific product  specifications.  Net profits
of the Joint  Venture  will be divided  80% to HIGA and 20% to the  Company.  On
November 30, 2010, the Company issued 36,000,000 shares of its restricted common
stock  valued at  $252,000  for EAC's 20%  investment  in the Joint  Venture  as
provided for in the Joint Venture  Agreement.  At December 31, 2010, the Company
recorded  an  impairment  of  $252,000  in  its  financial  statements  for  its
investment in the joint venture.  As of March 31, 2011, the business  activities
of the joint  venture  have not  started and it is not known to both the parties
when the joint venture is expected to start its business operations.

5. RELATED PARTY TRANSACTIONS

A related party paid Company's  obligations to vendors  amounting to $149,886 to
fund its  operations  as of March 31, 2011.  Advances  from  related  parties of
$149,886 and $122,559,  are due on demand,  non-interest  bearing and unsecured,
and are recorded as a current liability in the accompanying financial statements
as of March 31, 2011 and December 31, 2011, respectively.

                                       8
<PAGE>
On September 15, 2010,  the Company  acquired 100% of ownership  interest in EAC
from an officer of the  Company  for $100.  The  Company  has  recorded  $100 as
payable to related party in the  accompanying  financial  statements as of March
31, 2011and December 31, 2010.

On September  15, 2010,  the Company  issued  20,000  shares of preferred  stock
Series C,  $0.00001 par value,  valued at $12,000,  to an officer of the Company
for services performed.  The shares were valued at the fair value on the date of
issuance.  These  preferred  shares shall be entitled to convert into  2,000,000
shares of common stock  fully-paid  and  non-assessable  shares at any time. The
officer  shall have super voting rights and for voting  purposes,  each Series C
preferred share issued shall be counted as 10,000 shares of common stock per one
(1) share of Series C preferred stock.

On November 22, 2010, the Company issued a promissory  note in exchange of loans
made by a related party  amounting to $29,756.  The terms and  provisions of the
promissory note allowed for the related party to demand payment of this note, in
its  sole  discretion,  in the form of cash or  shares  of  common  stock of the
Company  to cancel  all or part of the  principal  amount of the note.  Upon the
related party's  election to receive  payments on the note in the form of shares
of Company's  common stock,  the number of shares called for to be issued at any
one time is to be  determined  by  dividing  the unpaid  principal  balance  and
accrued  interest  thereon,  of the  outstanding  indebtedness,  by a factor  of
$0.0003,  subject to a limitation that at no time will this provision  result in
any  holder of this note being  issued or  holding  more than 4.99% of the total
number  of  shares of the  Company's  common  stock  which  shall be issued  and
outstanding  at the time of such  conversion  and  exchanges.  During  the three
months  ended  March 31,  2011,  the  related  party  converted  $20,843  of the
promissory note into 69,477,619 common shares.  The Company recorded an interest
expense  of $477 on the  promissory  note as of March 31,  2011.  The  principal
balance due on the  promissory  note amounted to $8,913 and interest  accrued on
the promissory note amounted to $795 as of March 31, 2011.

The Company sub-leases its office facilities under a non-cancellable  lease from
a related party starting  January 1, 2010. The sub-lease term expires on July 1,
2011. Monthly rent of the sub-lease was $780 per month for the nine months ended
September 30, 2010.  Monthly rent increased to $2,030 per month starting October
1, 2010 due to the Company sub-leasing  additional office space from the related
party.  Rent expense from related party recorded in the  accompanying  financial
statements for the three months ended March 31, 2011 and 2010 amounted to $6,090
and $2,340,  respectively.  Future minimum sub-lease of rent payment  commitment
for the year ended December 31, 2011 amounted to $6,090.

6. CONVERTIBLE NOTES PAYABLE

On November 2, 2010,  the Company  executed a  convertible  promissory  note for
$10,000 with 8% interest per annum, payable quarterly after the first year, such
principal  and  interest  all due and payable at the end of three (3) years from
date hereof. The Company granted the Holder full recourse. The option granted by
the Company to Holder, as additional  consideration for said value received,  is
that the repayment for funds  provided by Holder shall,  at the sole election of
Holder, be made in whole or in part at any time at Holder's  discretion,  in the
form of shares of common  stock of the  Company  in lieu of cash  payments  due;
restricted  under SEC Rule 144, but granting the Holder piggy back  registration
rights  to have the  Company  include  such  shares  for  resale  on any  future
registration  of common  stock of the  Company,  including  but not  limited  to
Regulation A. Upon election and notification by Holder, the Company shall cancel
principal  and  interest  payments  due  and  convert  such  amounts  to  common
restricted shares of Holder at a set conversion price; such conversion price for
cancellation  of amounts of payment for  principal and interest due as described
hereunder is set at a price per share reflecting a 20% discount from the average
closing  bid price for  trading  of such  common  shares  for the  previous  ten
business day period;  however,  at no time will this provision  result in Holder
being  issued or  holding  more than a limit of 5% of the  Company's  issued and
outstanding  total common  shares at the time of such  conversions.  The Company
recorded an interest  expense of $200 for the three month period ended March 31,
2011.  The principal  balance  outstanding on the  convertible  note payable and
accrued interest payable at March 31, 2011 was $10,000 and $312, respectively.

                                       9
<PAGE>
On December 22, 2010,  the Company  executed a convertible  promissory  note for
$10,000 with 8% interest per annum, payable quarterly after the first year, such
principal  and  interest  all due and payable at the end of three (3) years from
date hereof.  The Company granted the Holder full recourse.  This option granted
by the Company to Holder,  as additional  consideration for said value received,
is that the repayment for funds  provided by Holder shall,  at the sole election
of Holder,  be made in whole or in part at any time at Holder's  discretion,  in
the form of shares of common stock of the Company in lieu of cash  payments due;
restricted  under SEC Rule 144, but granting the Holder piggy back  registration
rights  to have the  Company  include  such  shares  for  resale  on any  future
registration  of common  stock of the  Company,  including  but not  limited  to
Regulation A. Upon election and notification by Holder, the Company shall cancel
principal  and  interest  payments  due  and  convert  such  amounts  to  common
restricted shares of Holder at a set conversion price; such conversion price for
cancellation  of amounts of payment for  principal and interest due as described
hereunder is set at a price per share reflecting a 20% discount from the average
closing  bid price for  trading  of such  common  shares  for the  previous  ten
business day period;  however,  at no time will this provision  result in Holder
being  issued or  holding  more than a limit of 5% of the  Company's  issued and
outstanding  total common  shares at the time of such  conversions.  The Company
recorded an interest  expense of $200 for the three months ended March 31, 2011.
The principal  balance  outstanding on the convertible  note payable and accrued
interest payable at March 31, 2011 was $10,000 and $237, respectively.

7. COMMITMENTS AND CONTINGENCIES

A  securities  lawyer  claims  that  the  prior  control  group  of the  Company
contracted  with him on behalf of the Company to perform  securities  legal work
during the year ended December 31, 2009. The attorney claims he was paid $15,000
and is still owed $3,000. However, the attorney has not provided the new control
group with a contract  obligating the Company to pay.  Accordingly,  neither the
$18,000 of  expense,  nor the $3,000 in  liability,  has been  reflected  in the
Company's  financial  statements  as of March 31, 2011 and  December  31,  2010,
respectively.

8. STOCKHOLDERS' EQUITY

The  authorized  capital of the  Company as of March 31,  2011  consists  of (a)
100,000,000  preferred  shares with a par value of $0.00001 per share,  of which
5,000,000 shares are designated as Series A preferred shares with a par value of
$0.00001;  250,000 shares are designated as Series B preferred shares with a par
value of $0.00001; and 80,000 shares are designated as Series C preferred shares
with a par value of $0.00001,  and (b)  1,400,000,000  common  shares with a par
value of $0.00001 per share.

On October 8, 2010,  the  Company  amended  its  Articles  of  Incorporation  to
increase its authorized  capital for a total of One Billion Five Hundred Million
(1,500,000,000)  shares, One Billion Four Hundred Million (1,400,000,000) shares
of which are of common  stock,  $0.00001  par value per share,  and One  Hundred
Million  (100,000,000) shares of preferred stock,  $0.00001 par value, with Five
Million  (5,000,000) shares of preferred stock having previously been designated
as Series A, Two Hundred  Fifty  Thousand  (250,000)  shares of preferred  stock
having  previously  been  designated  as Series B and Eighty  Thousand  (80,000)
shares of preferred stock previously designated as Series C.

COMMON STOCK
In July 2007, the Company issued 45,000,000 shares of common stock at a price of
$0.0001 per share for total cash proceeds of $5,000. In August 2007, the Company
issued  36,000,000  shares  of common  stock at a price of $0.001  per share for
total cash  proceeds  of  $40,000.  In December  2007,  the Company  also issued
810,000  shares of common  stock at a price of $0.010  per share for total  cash
proceeds of $9,000.  During the period May 22, 2007  (inception) to December 31,
2007,  the Company sold a total of  81,810,000  shares of common stock for total
cash proceeds of $54,000.

On March 29,  2010,  the  Company  filed  with the Nevada  Secretary  of State a
Certificate of Designations  designating  5,000,000 shares of Series A Preferred
Stock,  $0.00001 par value per share. Each share is convertible at any time into
$1.00 of  Common  Stock of the  Company,  has a  liquidation  value of $1.00 per
share,  is not  entitled to any  dividends  and has no voting  rights other than
those prescribed the laws of the State of Nevada.

                                       10
<PAGE>
On March 29,  2010,  the  Company  filed  with the Nevada  Secretary  of State a
Certificate  of  Designations  designating  250,000 shares of Series B Preferred
Stock,  $0.00001 par value per share. Each share is convertible at any time into
$1.00 of  Common  Stock of the  Company,  has a  liquidation  value of $1.00 per
share,  is not  entitled to any  dividends  and has no voting  rights other than
those prescribed the laws of the State of Nevada.

On March 29,  2010,  the  Company  filed  with the Nevada  Secretary  of State a
Certificate  of  Designations  designating  80,000  shares of Series C Preferred
Stock,  $0.00001 par value per share.  Each share is convertible into 100 shares
of Common Stock of the  Company,  has  liquidation  rights equal to those of the
Company's  common  shares on an "as  converted"  basis,  is not  entitled to any
dividends  and has voting  rights  which  shall be counted on an "as  converted"
basis times 100.

On October 8, 2010,  the Company  issued to Enzyme Bio Sciences  LLC  50,000,000
shares of its common stock valued at $325,000 for its 40% share of investment in
a joint  venture.  On  November  30,  2010,  the  Company  issued  to HIGA  Inc.
36,000,000  shares of its common  stock  valued at $252,000 for its 20% share of
investment. The shares were issued at a fair value on the date issuance pursuant
to the terms of joint venture agreements.

During  November 30, 2010 and December 6, 2010,  the Company  issued  21,000,000
shares of its  common  stock  valued at  $630,000  to  certain  consultants  and
business  advisors for  services.  The common shares issued were valued at their
fair value on the date of issuances.

During the three months ended March 31, 2011,  the Company  issued (a) 9,500,000
shares of its common stock to consultants for services,  valued at $54,150,  (b)
12,500,000  shares of its common stock to officers and directors as compensation
for services,  valued at $86,250,  (c)  8,500,000  shares of its common stock to
independent  contractors for services valued at $58,650,  (d) 225,500,000 shares
of  its  common  stock  to its  wholly  owned  subsidiary  E  Clean  Acquisition
Corporation valued at $1,555,950 for acquisition of business  entities,  and (e)
69,477,619  shares of common stock to satisfy  indebtedness of $20,843 towards a
related party promissory note of $29,956 dated November 22, 2010.

In September  2009, the Company  forward-split  its common shares 9 for 1. As of
March  31,  2011  and  December  31,  2010,  the  Company  had  514,287,619  and
188,810,000  shares  of  common  stock  outstanding  taking  into  effect of the
forward-split of its common shares 9 for 1.

PREFERRED STOCK SERIES C
The Company's Articles of Incorporation  authorize the issuance of 80,000 shares
of $0.00001 par value Class C Preferred Stock. Under the Company's Articles, the
Board of Directors has the power,  without  further action by the holders of the
Common Stock,  to designate the relative rights and preferences of the preferred
stock, and issue the preferred stock in such one or more series as designated by
the Board of Directors.  The designation of rights and preferences could include
preferences as to liquidation,  redemption and conversion rights, voting rights,
dividends or other preferences,  any of which may be dilutive of the interest of
the holders of the Common Stock or the Preferred Stock of any other series.  The
issuance of  Preferred  Stock may have the effect of delaying  or  preventing  a
change in control of the  Company  without  further  shareholder  action and may
adversely affect the rights and powers,  including voting rights, of the holders
of Common Stock. In certain circumstances, the issuance of preferred stock could
depress the market price of the Common Stock.

The Series C preferred  shares  shall not be entitled to receipt of any dividend
and the Company's  board of directors shall not declare any dividends in respect
of the Series C preferred shares. The holders of Series C preferred shares shall
be entitled to convert  each whole  number of Series C preferred  share into 100
shares of  common  stock  issuable  upon  conversion.  The  holders  of Series C
preferred  shares and the holders of common stock shall vote together and not as
separate  classes.  For voting purposes,  each Series C preferred share shall be
counted as 10,000 shares of common stock per one (1) share of Series C preferred

                                       11
<PAGE>
stock. For the purposes of calculating the number of shares to be voted and only
for such  purpose,  the  Series C  preferred  shares  shall be deemed  not to be
subject to any reverse split of the common stock of the Company. In the event of
any  voluntary  or  involuntary  liquidation,  dissolution  or winding up of the
Company,  the  holders  of Series C  preferred  shares  shall  have  liquidation
preference equal to that of the holders of common stock of the Company, and each
Series C preferred  share shall be counted as 10,000  shares of common stock per
one (1) share of Series C  preferred  share.  All  shares of Series C  preferred
stock  shall be junior  rank to all  shares of Series A and  Series B  preferred
shares in respect to all preferences as to  distributions  and payments upon the
liquidation, dissolution and winding up of the Company.

The Company shall not effectuate any conversion of any Series C preferred  share
and no holder of any Series C  preferred  share  shall have the right to convert
and Series C  preferred  share to the extent  that after  giving  effect to such
conversion  such  person  (together  with such  person's  affiliates)  (a) would
beneficially own in excess of 4.9% of the outstanding shares of the common stock
following such conversion and (B) would have acquired, through conversion of any
Series C preferred share or otherwise (including without limitation, exercise of
any warrant),  in excess of 4.9% of the  outstanding  shares of the common stock
following such conversion.

On September  15, 2010,  the Company  issued  20,000  shares of preferred  stock
Series C,  $0.00001 par value,  valued at $12,000,  to an officer of the Company
for services performed. These preferred shares shall be entitled to convert into
2,000,000  shares of common stock  fully-paid and  non-assessable  shares at any
time. The officer shall have super voting rights and for voting  purposes,  each
Series C  preferred  share  issued  shall be counted as 10,000  shares of common
stock per one (1) share of Series C preferred stock.

As of  March  31,  2011,  20,000  shares  of  preferred  stock  Series  C remain
outstanding.

9. SUBSEQUENT EVENTS

The Company has evaluated subsequent events through May 10, 2011, the date which
the financial statements were available to be issued.

On May 5, 2011, the Company issued a news release concerning the cancellation of
its joint venture with HIGA Corporation  effective May 9, 2011. As a part of the
restructuring of the Company's business  opportunities,  this will result in the
cancellation of 36 million shares of common stock previously issued to the joint
venture will be returned to the Company and treated as treasury stock.

                                       12
<PAGE>
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
        OF OPERATION.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

Certain  statements  contained  in this  Quarterly  Report  on Form 10-Q for the
quarterly period ended March 31, 2011 constitute  "forward-looking  statements."
These statements,  identified by words such as "plan," "anticipate,"  "believe,"
"estimate," "should," "expect," and similar expressions include our expectations
and objectives  regarding our future financial  position,  operating results and
business strategy. These statements reflect the current views of management with
respect to future  events  and are  subject  to risks,  uncertainties  and other
factors  that may cause our actual  results,  performance  or  achievements,  or
industry  results,  to be  materially  different  from  those  described  in the
forward-looking statements. Such risks and uncertainties include those set forth
under the caption  "Management's  Discussion and Analysis of Financial Condition
and Results of Operation" and elsewhere in this Quarterly  Report. We advise you
to carefully review the reports and documents we file from time to time with the
Securities and Exchange  Commission (the "SEC"),  particularly our Annual Report
on Form 10-K, our Quarterly Reports on Form 10-Q and our Current Reports on Form
8-K.

As used in this Quarterly Report,  the terms "we," "us," "our," "Global NuTech,"
and the "Company"  refer to Global  NuTech,  Inc.,  formerly known as Bio-Clean,
Inc. and Nature of Beauty, Inc., unless otherwise indicated.  All dollar amounts
in this  Quarterly  Report  are  expressed  in U.S.  dollars,  unless  otherwise
indicated.

INTRODUCTION

The  Company was  incorporated  under the laws of the State of Nevada on May 22,
2007.  The Company is in the  development  stage as defined  under  Statement on
Financial  Accounting  Standards No. 7,  Development  Stage  Enterprises  ("SFAS
No.7"). Historically, the Company has been engaged in the business of purchasing
and  distributing  all-natural  and organic  everyday  skin care  products  from
Russia. As of the date of this Quarterly Report, we have not commenced  business
operations  and we have not  generated  any  revenues  from the  beauty  product
business.  In the later  part of 2009,  the  Company's  management  and Board of
Directors  deemed  it to be in  the  best  interests  of  the  Company  and  its
stockholders for the Company to diversify its holdings across a broader range of
industry  segments.  Doing so would provide greater growth  potential as well as
balance  cyclical  downturns.  On  October  16,  2009,  we  changed  our name to
Bio-Clean,   Inc.  and  commenced  work  on  developing   "green"  products  and
technologies,  including unique cleaning and environmental remediation products.
In September  2010,  we again changed our name to Global  NuTech,  Inc. The name
change better denotes the multi-faceted  lines of business in which we intend to
operate.  With the increase in authorized shares of our common stock will permit
us to further expand our operations through future acquisitions or joint venture
arrangements. The change of name became effective on October 8, 2010.

RESULTS OF OPERATION

We are a  development  stage company and have not generated any revenue to date.
We have incurred  recurring  losses to date. Our financial  statements have been
prepared assuming that we will continue as a going concern and, accordingly,  do
not include adjustments relating to the recoverability and realization of assets
and classification of liabilities that might be necessary should we be unable to
continue in operation.  We expect we will require additional capital to meet our
long term operating requirements. We expect to raise additional capital through,
among other things, the sale of equity or debt securities.

The summarized  financial data is derived from and should be read in conjunction
with our unaudited  financial  statements for the three-month period ended March
31, 2011,  including the notes to those financial  statements which are included
in this Quarterly  Report.  The following  discussion  contains  forward-looking
statements  that reflect our plans,  estimates and beliefs.  Our actual  results
could differ materially from those discussed in the forward-looking  statements.
Our unaudited  financial  statements are stated in United States Dollars and are
prepared  in  accordance  with  United  States  Generally  Accepted   Accounting
Principles.

                                       13
<PAGE>
THREE-MONTH PERIOD ENDED MARCH 31, 2011 COMPARED TO THE THREE-MONTH PERIOD ENDED
MARCH 31, 2010.

Our net loss for the  three-month  period  ended  March  31,  2011 was  $252,902
compared  to a net loss of $21,258  during the same  comparable  period in 2010.
During the  three-month  period  ended March 31,  2011,  we did not generate any
revenue.

During the  three-month  period  ended March 31, 2011,  we incurred  general and
administrative  expenses of $99,975 as compared to $21,258  incurred  during the
same comparable  period in 2010.  General and  administrative  expenses incurred
during  the  three-month  period  ended  March 31,  2011,  primarily  related to
corporate  overhead,  financial and administrative  contracted  services such as
legal, professional, accounting and audit fees.

During the three-month period ended March 31, 2011, we incurred  compensation to
officers for services of $151,250  compared to no compensation  paid to officers
for services during the same comparable period in 2010.

Our net loss during the three-month  period ended March 31, 2011 was $252,902 or
$0.00 per share  compared  to a net loss of  $21,258  or $0.00 per share for the
comparable  period in 2010. Our cumulative loss from May 22, 2007 (inception) to
March 31, 2011 amounted to  $1,698,694.  The weighted  average  number of common
shares  outstanding was  319,360,150 and 81,810,000 for the three-month  periods
ended March 31, 2011 and 2010, respectively.

LIQUIDITY AND CAPITAL RESOURCES

THREE-MONTH PERIOD ENDED MARCH 31, 2011

As of March 31, 2011, our current  assets were $941 and our current  liabilities
were  $186,742,  which  resulted  in  negative  working  capital of  $185,801 as
compared to negative working capital of $152,792 at December 31, 2010.

At March 31, 2011, current liabilities comprised of accrued expenses of $27,943,
a note  payable of $8,913 and advances  from  related  parties of $149,886 for a
total of $186,742 as compared to $153,781 in current liabilities at December 31,
2010. The increase in current  liabilities  during the three-month  period ended
March 31, 2011 from  December  31,  2010 was  primarily  due to advances  from a
related  party for  payment of  corporate  and  administrative  overhead  of the
Company.

Stockholders' equity decreased from a capital deficiency of $172,792 at December
31, 2010 to capital deficiency of $205,801 at March 31, 2011.

CASH FLOWS FROM OPERATING ACTIVITIES

Net cash used by operating activities for the three-month period ended March 31,
2011  amounted to $48 due to issuances of common stock for services  rendered by
officers and third parties totaling  $199,050 and advancements made by a related
party for administrative expenses totaling $27,327.

CASH FLOWS FROM INVESTING AND FINANCING ACTIVITIES

We had no cash flows from investing  activities and financing  activities during
the three-month period ended March 31, 2011.

We expect that working capital  requirements  will continue to be funded through
loans or the further issuances of securities.  Our working capital  requirements
are expected to increase in line with the growth of our business.

PLAN OF OPERATION AND FUNDING

Our cash reserves are not sufficient to meet our obligations for the next twelve
month period. As a result,  we will need to seek additional  funding in the near
future.  We  currently  do not have a specific  plan of how we will  obtain such
funding;  however,  we anticipate that additional funding will be in the form of

                                       14
<PAGE>
equity  financing from the sale of shares of our common stock.  We may also seek
to obtain short-term loans from our directors or unrelated parties,  although no
such arrangements have been made. At this time, we cannot provide investors with
any assurance that we will be able to obtain sufficient funding from the sale of
our common stock or through a loan from our  directors  or unrelated  parties to
meet  our  obligations  over  the  next  twelve  months.  We  do  not  have  any
arrangements in place for any future equity financing.

MATERIAL COMMITMENTS

As of March 31, 2011, we had no material commitments.

PURCHASE OF SIGNIFICANT EQUIPMENT

We do not intend to purchase any  significant  equipment  during the next twelve
months.

OFF-BALANCE SHEET ARRANGEMENTS

We do not have any off-balance  sheet  arrangements  that have or are reasonably
likely to have a current or future effect on our financial condition, changes in
financial  condition,  revenues or expenses,  results of operations,  liquidity,
capital expenditures or capital resources that are material to investors.

GOING CONCERN

The independent  auditors'  report  accompanying our December 31, 2010 financial
statements contained an explanatory paragraph expressing substantial doubt about
our ability to continue as a going concern.  The financial  statements have been
prepared "assuming that we will continue as a going concern," which contemplates
that we will realize our assets and satisfy our  liabilities  and commitments in
the ordinary course of business.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES.

The Company, under the supervision and with the participation of its management,
including the Chief Executive  Officer/Chief  Financial  Officer,  evaluated the
effectiveness of the design and operation of the Company's  "disclosure controls
and procedures" (as defined in Rule 13a-15(e) under the Securities  Exchange Act
of 1934, as amended,  as of the end of the period covered by this report.  Based
on  that  evaluation,   the  Chief  Executive  Officer/Chief  Financial  Officer
concluded that the Company's  disclosure  controls and procedures were effective
as of March 31, 2011. There has been no change in the Company's internal control
over  financial  reporting  during the quarter  ended March 31,  2011,  that has
materially affected, or is reasonably likely to materially affect, the Company's
internal control over financial reporting.

                           PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

We are not a party to any material legal  proceedings and, to our knowledge,  no
such proceedings are threatened or contemplated.

ITEM 1A. RISKS FACTORS.

Not applicable.

                                       15
<PAGE>
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

On February 22, 2011, the Company issued  10,000,000  shares of its common stock
to E. G. Marchi, our President,  and 2,500,000 to Sean Stanowski, our Secretary,
as compensation for services rendered.  On February 22, 2011, the Company issued
225,500,000 shares to its wholly owned subsidiary,  E-Clean  Acquisitions,  Inc.
This  stock was  issued to allow the  subsidiary  entity to enter into and close
acquisitions  of other  business  entities on behalf of the Company.  During the
quarter  ended March 31, 2011,  the Company  issued an  aggregate of  18,000,000
shares of its common stock to unrelated  third parties for services  rendered to
the  Company.  During the quarter  ended March 31, 2011,  the Company  issued an
aggregate of 69,477,619 shares of its common stock upon conversion of $20,843 of
the Promissory Note dated November 22, 2011 with an original  principal  balance
of $29,956.  All of the shares of common stock were issued pursuant an exemption
provided by Section 4(2) of the Securities Act of 1933.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. (REMOVED AND RESERVED).

ITEM 5. OTHER INFORMATION.

On May 3, 2011,  the Company  announced that it had made a decision to focus its
business on the  Technology  and Energy  markets and to undergo a major  capital
restructuring  of  various  joint  venture  entered  into  by its  wholly  owned
subsidiary,  E-Clean  Acquisitions,  Inc. which will result in a cancellation of
approximately  350,000,000 shares of its common stock currently outstanding.  In
connection with this  restructuring,  on May 5, 2011, the Company announced that
its joint venture with HIGA Corporation would be cancelled and 36,000,000 shares
of the  Company's  common stock issued to the joint venture would be returned to
the Company and treated as treasury stock.

ITEM 6. EXHIBITS.

The following exhibits are filed as part of this Quarterly Report.

<TABLE>
<CAPTION>
Exhibit No.           Description of Exhibit                                  Location
-----------           ----------------------                                  --------
<S>          <C>                                           <C>
   3.1        Articles of Incorporation                     Incorporated by reference to Exhibit 3.1 to the
                                                            Company's Registration Statement on Form S-1 as
                                                            filed with the Securities and Exchange Commission
                                                            on  March 21, 2008, as subsequently amended.

   3.2        Bylaws                                        Incorporated by reference to Exhibit 3.2 to the
                                                            Company's Registration Statement on Form S-1 as
                                                            filed with the Securities and Exchange Commission
                                                            on March 21, 2008, as subsequently amended.

   3.3        Certificate of Amendment to Certificate       Incorporated by reference to the Schedule 14C
              of Incorporation filed with the Nevada        Definitive Information Statement filed with the
              Nevada Secretary of State on October 8,       Securities and Exchange Commission on October on
              2009.                                         October September 18, 2009.

   3.4        Certificate of Designation of Series A        Incorporated by reference to Exhibit 3.4 of the
              Convertible Preferred Stock filed with        Company's Annual Report on Form 10-K filed
              the Nevada Secretary of State on March        With the Securities and Exchange Commission on
              29, 2010.                                     May 17, 2010.
</TABLE>

                                       16
<PAGE>
<TABLE>
<CAPTION>
<S>          <C>                                           <C>
   3.5        Certificate of Designation of Series B        Incorporated by reference to Exhibit 3.5 of the
              Convertible Preferred Stock filed with        Company's Annual Report on Form 10-K filed
              the Nevada Secretary of State on March        With the Securities and Exchange Commission on
              29, 2010.                                     May 17, 2010.

   3.6        Certificate of Designation of Series C        Incorporated by reference to Exhibit 3.6 of the
              Convertible Preferred Stock filed with        Company's Annual Report on Form 10-K filed
              the Nevada Secretary of State on March        with the Securities and Exchange Commission on
              29, 2010.                                     May 17, 2010.

  21.1        Subsidiaries.                                 Included herein.

  31.1        Certification of Chief Executive Officer      Included herein.
              pursuant to Section 302 of the
              Sarbanes-Oxley Act of 2002.

  31.2        Certification of Chief Financial Officer      Included herein.
              pursuant to Section 302 of the
              Sarbanes-Oxley Act of 2002.

  32.1        Certification of Chief Executive Officer      Included herein.
              pursuant to 18 U.S.C.Section 1350.

  32.2        Certification of Chief Executive Officer      Included herein.
              pursuant to 18 U.S.C.Section 1350.
</TABLE>

                                       17
<PAGE>
                                   SIGNATURES

In  accordance  with  Section 13 or 15(d) of the Exchange  Act,  the  registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

                                       GLOBAL NUTECH, INC.


Date: May 13, 2011                     By: /s/ E. G. Marchi
                                           -------------------------------------
                                           E. G. Marchi
                                           President

                                       18